Galen buys licence for generic contraception
Northern pharmaceutical company Galen Holdings has said it bought an exclusive licence for a generic version of Galen's Ovcon 35 oral contraceptive from Barr Pharmaceuticals, for €19m
(€15.74m).
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





